- Language: English
- 347 Pages
- Published: April 2012
- Region: Global
Electrophysiology (EP) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
- Published: April 2013
- Region: Africa, Brazil, China, India, Russia, South Africa
- 624 Pages
- Axis Research Mind
BRICSS Market Watch:
The broad ‘health care' division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead.
BRICSS electrophysiology devices market forecasts are expected to reach at US$0.84 million by 2015 at a CAGR of 10.5% during the analysis period 2009-2015. China accounts for nearly 24% of the global value and India also claims a closer percentage of the market. In terms of CAGR, China is the fastest growing regions while India and South Korea are just behind. Among the product types, diagnostic electrophysiology catheters account for nearly 70% of the market value while laboratory devices and ablation catheters round off to 30%. Forecasts for BRICSS conventional diagnostic EP segment indicate more than 50% of the diagnostic EP market by 2015 leaving the rest of the market to the advanced and ultrasound types.
Considering ablation catheters, the RF segment indicates more than 40% by 2015 while cryo, laser and microwave types add up to the remaining 60%. Estimates of BRICSS EP X-ray market value indicate more than 35% by 2015 the rest of the portion is filled by 3D mapping, recording, remote steering, intra cardiac ECG and RF ablation generators.
The report ‘Electrophysiology (EP) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa and South Korea), 2009-2015' reviews the latest trends in EP segment with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations.
The report primarily focuses on:
- Emerging Market Trends
- Advancements in the Technological Space
- Market Demand Of The Segments (By-Region)
- Key Growth Areas and Market Size
- Region-Wise Demand Factor
- Key Competitors Edge
- Investment Strategies
The report covers the market analysis by product types. The subdivisions are as:
1. Diagnostic Electrophysiology Catheters
a. Conventional EP Diagnostic Catheters (fixed and steerable)
b. Advanced EP Diagnostic Catheters (loop and other)
c. Ultrasound EP Diagnostic Catheters
2. EP Laboratory Devices
a. X-Ray Systems
b. 3D Mapping Systems
c. EP Recording Systems
d. Remote Steering Systems
e. Intracardiac Echocardiography Systems
f. Radiofequency (RF) Ablation Generators
3. EP Ablation Catheters
a. Radiofequency (RF) EP Ablation Catheters (Conventional & Irrigated-Tip)
b. Cryoablation EP Catheters
c. Laser Ablation Systems
d. Navigational Advanced Mapping Accessories
e. Microwave Ablation
The period considered for the market analysis is 2009-2015. The region wise distribution of the market consists of Emerging Markets Brazil, Russia, India, China, South Africa and South Korea. Incorporating the recession impacts on the industry, the market growth rate in these economies are estimated individually for the upcoming years.
More than 700 leading market players are identified and 95 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 133 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry. SHOW LESS READ MORE >
- Abbott Vascular Devices
- atricure, Inc
- Abiomed, Inc.
- Advansource Biomaterials
- Aga Medical Corporation
- Atrium Medical Corp.
- Ats Medical, Inc.
- Biophan Technologies, Inc.
- Biosense Webster, Inc.
- Boston Scientific Corp
- Cardiac Science Corp.
- Cardiacassist, Inc.
- Cardica, Inc.
- Cardiomems, Inc.
- Cook Group Incorporated
- Cordis Corporation
- Cryolife Inc.
- Idev Technologies
- Medtronic, Inc.
... and many more